Search Results 11-20 of 4909 for Wegovy

  1. Childhood obesity - Diagnosis and treatment - Mayo Clinic

    Medicines that may boost weight loss include: Semaglutide (Wegovy). Liraglutide (Saxenda). Phentermine and topiramate (Qsymia). Phentermine. Lisdexamfetamine.

  2. Obesity - Diagnosis and treatment - Mayo Clinic

    Semaglutide (Ozempic, Rybelsus, Wegovy). Tirzepatide (Mounjaro, Zepbound). Weight-loss medicines may not work for everyone, and the effects may wane over ...

  3. Pseudotumor cerebri (idiopathic intracranial hypertension) - Diagnosis & treatment - Mayo Clinic

    Glucagon-like peptide 1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy, others) can help people lose weight and may also reduce pressure in ...

  4. Mayo Clinic Minute: What's the skinny on weight-loss drugs? VIDEO AUDIO It's a medication called semaglutide — better known by

    VIDEO. AUDIO. It's a medication called semaglutide — better known by the brand names Ozempic and Wegovy. Ozempic is approved by the Food and Drug.

  5. Bariatric Center in Jacksonville - Your first appointment - Mayo Clinic

    Any prescriptions provided by your doctor, such as glucagon-like peptide 1 (GLP-1) medications like Wegovy or Zepbound, or other obesity medications such as ...

  6. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    A Mayo Clinic study finds no overall increase in thyroid cancer risk with GLP-1RA therapy, suggesting early diagnoses likely reflect detection bias, ...

  7. Mayo Clinic Q and A: Weight loss and genetics

    Semaglutide medications such as Wegovy, Ozempic and Rybelsus work on behalf of the GLP-1 hormone. They connect between the gut and the brain, and they ...

  8. Diuretics: Cause of gout? - Mayo Clinic

    This treatment for high blood pressure can raise the risk of arthritis. Find out why and what you can do about it.

  9. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    A Mayo Clinic study finds postmenopausal women using hormone therapy lost 35% more weight with tirzepatide, suggesting new obesity treatment strategies.

  10. Trevogrumab or Trevogrumab with Garetosmab when taken with Semaglutide in patients with obesity. - Mayo Clinic

    Have any contraindication to semaglutide as per Wegovy product labeling. Have previously had intolerance to GLP-1 agonist therapy resulting in treatment ...